Bio-Thera Solutions Ltd (688177) - Cash Flow Conversion Efficiency

Latest as of June 2023: -0.054x

Based on the latest financial reports, Bio-Thera Solutions Ltd (688177) has a cash flow conversion efficiency ratio of -0.054x as of June 2023. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (CN¥-72.53 Million ≈ $-10.61 Million USD) by net assets (CN¥1.35 Billion ≈ $198.09 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. Also see 688177 stock market capitalisation for the company's overall valuation and market capitalisation.

Bio-Thera Solutions Ltd - Cash Flow Conversion Efficiency Trend (2016–2025)

This chart illustrates how Bio-Thera Solutions Ltd's cash flow conversion efficiency has evolved over time, based on yearly financial data.

Bio-Thera Solutions Ltd Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Bio-Thera Solutions Ltd ranked by their cash flow conversion efficiency. Explore Bio-Thera Solutions Ltd earnings quality ratio to measure how well operating cash flow supports reported net income.

Company	Cash Flow Conversion Efficiency
UTI Asset Management Company Limited NSE:UTIAMC	0.005x
Sonic Automotive Inc NYSE:SAH	0.036x
Two Harbors Investments Corp NYSE:TWO	0.033x
NAPCO Security Technologies Inc NASDAQ:NSSC	0.072x
Fras-le S.A SA:FRAS3	0.130x
TD Power Systems Limited NSE:TDPOWERSYS	0.012x
Xiamen Solex High-Tech Industries Co Ltd SHG:603992	0.021x
Camel Group Co Ltd SHG:601311	0.017x

Annual Cash Flow Conversion Efficiency for Bio-Thera Solutions Ltd (2016–2025)

The table below shows the annual cash flow conversion efficiency of Bio-Thera Solutions Ltd from 2016 to 2025. View Bio-Thera Solutions Ltd (688177) share price today for real-time trading data and today's change.

Year	Net Assets	Operating Cash Flow	Cash Flow Conversion Efficiency	Change
2025-12-31	CN¥376.03 Million ≈ $55.03 Million	CN¥-82.11 Million ≈ $-12.02 Million	-0.218x	-177.83%
2024-12-31	CN¥708.09 Million ≈ $103.62 Million	CN¥-55.65 Million ≈ $-8.14 Million	-0.079x	+79.32%
2023-12-31	CN¥1.21 Billion ≈ $177.46 Million	CN¥-460.87 Million ≈ $-67.44 Million	-0.380x	-47.96%
2022-12-31	CN¥1.61 Billion ≈ $235.19 Million	CN¥-412.82 Million ≈ $-60.41 Million	-0.257x	-326.93%
2021-12-31	CN¥2.09 Billion ≈ $305.47 Million	CN¥236.27 Million ≈ $34.57 Million	0.113x	+163.40%
2020-12-31	CN¥2.01 Billion ≈ $293.48 Million	CN¥-358.04 Million ≈ $-52.39 Million	-0.179x	+81.17%
2019-12-31	CN¥630.67 Million ≈ $92.29 Million	CN¥-597.98 Million ≈ $-87.50 Million	-0.948x	-43.83%
2018-12-31	CN¥801.32 Million ≈ $117.26 Million	CN¥-528.25 Million ≈ $-77.30 Million	-0.659x	+3.20%
2017-12-31	CN¥347.55 Million ≈ $50.86 Million	CN¥-236.68 Million ≈ $-34.63 Million	-0.681x	-213.27%
2016-12-31	CN¥534.43 Million ≈ $78.20 Million	CN¥-116.18 Million ≈ $-17.00 Million	-0.217x	--

About Bio-Thera Solutions Ltd

SHG:688177 China Biotechnology

Market Cap

$1.28 Billion

CN¥8.74 Billion CNY

Market Cap Rank

#7926 Global

#1817 in China

Share Price

CN¥21.10

Change (1 day)

+8.99%

52-Week Range

CN¥16.10 - CN¥29.53

All Time High

CN¥71.90